180 related articles for article (PubMed ID: 26562548)
21. Preparation, characterization and
Mosafer J; Sabbaghi AH; Badiee A; Dehghan S; Tafaghodi M
Asian J Pharm Sci; 2019 Mar; 14(2):216-221. PubMed ID: 32104453
[TBL] [Abstract][Full Text] [Related]
22. Greener approach for synthesis of N,N,N-trimethyl chitosan (TMC) using ternary deep eutectic solvents (TDESs).
Mahajan T; Bangde P; Dandekar P; Jain R
Carbohydr Res; 2020 Jul; 493():108033. PubMed ID: 32505997
[TBL] [Abstract][Full Text] [Related]
23. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
24. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers.
Mao S; Shuai X; Unger F; Wittmar M; Xie X; Kissel T
Biomaterials; 2005 Nov; 26(32):6343-56. PubMed ID: 15913769
[TBL] [Abstract][Full Text] [Related]
26. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
27. Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride.
Polnok A; Borchard G; Verhoef JC; Sarisuta N; Junginger HE
Eur J Pharm Biopharm; 2004 Jan; 57(1):77-83. PubMed ID: 14729082
[TBL] [Abstract][Full Text] [Related]
28. The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake.
Jintapattanakit A; Junyaprasert VB; Kissel T
J Pharm Sci; 2009 Dec; 98(12):4818-30. PubMed ID: 19408295
[TBL] [Abstract][Full Text] [Related]
29. Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.
Tsai LC; Chen CH; Lin CW; Ho YC; Mi FL
Int J Biol Macromol; 2019 Apr; 126():141-150. PubMed ID: 30586591
[TBL] [Abstract][Full Text] [Related]
30. Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs.
Clementino AR; Pellegrini G; Banella S; Colombo G; Cantù L; Sonvico F; Del Favero E
Mol Pharm; 2021 Aug; 18(8):3132-3146. PubMed ID: 34259534
[TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization, and evaluation of 3,6-O-N-acetylethylenediamine modified chitosan as potential antimicrobial wound dressing material.
Dang Q; Liu K; Liu C; Xu T; Yan J; Yan F; Cha D; Zhang Q; Cao Y
Carbohydr Polym; 2018 Jan; 180():1-12. PubMed ID: 29103484
[TBL] [Abstract][Full Text] [Related]
32. Preparation and cytotoxicity of N-modified chitosan nanoparticles applied in curcumin delivery.
Facchi SP; Scariot DB; Bueno PV; Souza PR; Figueiredo LC; Follmann HD; Nunes CS; Monteiro JP; Bonafé EG; Nakamura CV; Muniz EC; Martins AF
Int J Biol Macromol; 2016 Jun; 87():237-45. PubMed ID: 26930578
[TBL] [Abstract][Full Text] [Related]
33. Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: From synthesis to in vitro application.
Benediktsdóttir BE; Baldursson Ó; Másson M
J Control Release; 2014 Jan; 173():18-31. PubMed ID: 24511609
[TBL] [Abstract][Full Text] [Related]
34. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
35. Shielding effect of 'surface ion pairs' on physicochemical and bactericidal properties of N,N,N-trimethyl chitosan salts.
Martins AF; Facchi SP; Follmann HD; Gerola AP; Rubira AF; Muniz EC
Carbohydr Res; 2015 Jan; 402():252-60. PubMed ID: 25498028
[TBL] [Abstract][Full Text] [Related]
36. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
37. Trimethyl chitosan and its applications in drug delivery.
Mourya VK; Inamdar NN
J Mater Sci Mater Med; 2009 May; 20(5):1057-79. PubMed ID: 19112609
[TBL] [Abstract][Full Text] [Related]
38. Preparation of N, N, N-trimethyl chitosan via a novel approach using dimethyl carbonate.
Wu M; Long Z; Xiao H; Dong C
Carbohydr Polym; 2017 Aug; 169():83-91. PubMed ID: 28504181
[TBL] [Abstract][Full Text] [Related]
39. Nasal inserts containing ondansetron hydrochloride based on Chitosan-gellan gum polyelectrolyte complex: In vitro-in vivo studies.
Sonje AG; Mahajan HS
Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():329-335. PubMed ID: 27127060
[TBL] [Abstract][Full Text] [Related]
40. Quaternized trimethyl functionalized chitosan based antifungal membranes for drinking water treatment.
Tabriz A; Ur Rehman Alvi MA; Khan Niazi MB; Batool M; Bhatti MF; Khan AL; Khan AU; Jamil T; Ahmad NM
Carbohydr Polym; 2019 Mar; 207():17-25. PubMed ID: 30599997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
